May 05, 2025

Current Landscape of Therapies for Transthyretin Amyloid Cardiomyopathy

Read more

Apr 29, 2025

Reliability and validity of the Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire impact scales

Read more

Apr 28, 2025

Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China

Read more

Apr 16, 2025

More players in the treatment of transthyretin amyloidosis? The HELIOS-B study

Read more

Apr 09, 2025

Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up

Read more

Apr 02, 2025

Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry

Read more

Apr 02, 2025

Amyloid-reoriented enzyme catalysis

Read more

Apr 02, 2025

Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer’s dementia continuum: an [18 F] AV-45 study

Read more

Apr 02, 2025

Incidental acute cholecystitis as a gateway to the diagnosis of AL cardiac amyloidosis

Read more

Apr 02, 2025

Role of Tag Team Rounds in Accurate Diagnosis and Management of Cardiac Amyloidosis

Read more

Subscribe to